Latest Articles
Retraction Note: NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response - BMC Medicine
Retraction Note: NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response BMC Medicine
Published: Sept. 20, 2025, 4:22 a.m.
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway - Nature
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway Nature
Published: April 10, 2025, 6:55 a.m.
Personalized therapy in endometriosis — based on ERα or ERβ expression - BMC Medicine
Personalized therapy in endometriosis — based on ERα or ERβ expression BMC Medicine
Published: May 30, 2024, 7 a.m.
Link copied to clipboard!